Fungitell Specificity for Fungal Infections
Fungitell is a diagnostic test that detects (1,3)-β-D-glucan, a cell wall component present in multiple fungal species, but is not specific for any single fungal pathogen. 1
Fungal Pathogens Detected by Fungitell
Fungitell can detect the presence of:
- Candida species
- Aspergillus species
- Pneumocystis jirovecii
- Fusarium species
- Acremonium species
However, Fungitell notably does not detect:
- Mucorales (causative agents of mucormycosis) due to lack of significant (1,3)-β-D-glucan in their cell walls
- Cryptococcus species (have low levels of (1,3)-β-D-glucan)
Diagnostic Performance
The Fungitell assay demonstrates:
- Sensitivity of approximately 75-80% for invasive candidiasis 1
- Specificity of approximately 80% for invasive fungal infections 1
- High negative predictive value (>85%), making it more useful for excluding fungal infection than confirming it 1, 2
Clinical Applications
Fungitell is FDA-approved as an adjunct to cultures for diagnosing invasive fungal infections, not as a standalone diagnostic test 1. Its primary utility includes:
- Early detection: Can identify invasive candidiasis days to weeks before positive blood cultures 1
- Monitoring response: Decreasing β-D-glucan levels may correlate with response to antifungal therapy 1
- Screening: May be used in high-risk patients, particularly when combined with other diagnostic methods 1
Limitations and False Positives
False positive results can occur with:
- Hemodialysis
- Administration of albumin or immunoglobulins
- Certain antibiotics (particularly some β-lactams like piperacillin-tazobactam)
- Blood product transfusions
- Use of glucan-contaminated blood collection tubes or gauze
- Bacterial infections (particularly gram-positive bacteremia) 1, 2
Diagnostic Strategy
For optimal diagnostic value:
- Serial testing (twice weekly) is recommended rather than a single measurement 1
- Combine with other diagnostic methods such as cultures, imaging, and other biomarkers
- Consider as part of a comprehensive diagnostic approach rather than relying solely on Fungitell results 2
Clinical Recommendation
The Fungitell assay should be used as part of a comprehensive diagnostic strategy for invasive fungal infections, with recognition that a negative result has greater utility for excluding infection than a positive result has for confirming it. 1, 2
When interpreting results, clinicians should consider the patient's risk factors, clinical presentation, and results of other diagnostic tests, while being aware of potential causes of false positive results.